deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT00673075

The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease

Efficacy and Tolerability of Nebivolol Compared With Carvedilol in Patients With Coronary Artery Disease and Stage I or II Hypertension

Sponsor: Forest Laboratories

Updated 10 times since 2017 Last updated: Sep 2, 2010 Started: May 31, 2008 Primary completion: Sep 30, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Coronary Artery Disease and Hypertension, this trial is completed. The trial is conducted by Forest Laboratories and has accumulated 10 data snapshots since 2008. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 9 months · monthly snapshotCompleted

Change History

10 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  5. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

Show 5 earlier versions
  1. Dec 2021 — Dec 2022 [monthly]

    Completed PHASE4

  2. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE4

  3. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  4. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE4

  5. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

May 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Forest Laboratories
Data source: Forest Laboratories

For direct contact, visit the study record on ClinicalTrials.gov .